Vitamin C Prevents Cigarette Smoke–Induced Pulmonary Emphysema in Mice and Provides Pulmonary Restoration
- 1 February 2014
- journal article
- Published by American Thoracic Society in American Journal of Respiratory Cell and Molecular Biology
- Vol. 50 (2), 347-357
- https://doi.org/10.1165/rcmb.2013-0121oc
Abstract
Vitamin C (VC) is a potent antioxidant and is essential for collagen synthesis. We investigated whether VC treatment prevents and cures smoke-induced emphysema in senescence marker protein-30 knockout (SMP30-KO) mice, which cannot synthesize VC. Two smoke-exposure experiments using SMP30-KO mice were conducted. In the first one (a preventive study), 4-month-old mice received minimal VC (0.0375 g/l) [VC(L)] or physiologically sufficient VC (1.5 g/l) [VC(S)] and exposed to cigarette smoke or smoke-free air for 2 months. Pulmonary evaluations followed when the mice were 6 months of age. The second study began after the establishment of smoke-induced emphysema (a treatment study). These mice no longer underwent smoke exposure but received VC(S) or VC(L) treatment for 2 months. Morphometric analysis was performed, and measurements of oxidative stress, collagen synthesis, and vascular endothelial growth factor in the lungs were evaluated. Chronic smoke exposure caused emphysema (29.6% increases of mean linear intercepts [MLI] and 106.5% increases of destructive index compared with the air-only group) in 6-month-old SMP30-KO mice, and this emphysema closely resembled human chronic obstructive pulmonary disease. Smoke-induced emphysema persisted in the VC(L) group after smoking cessation, whereas VC treatment provided pulmonary restoration (18.5% decrease of MLI and 41.3% decrease of destructive index compared with VC(L) group). VC treatment diminished oxidative stress, increased collagen synthesis, and improved vascular endothelial growth factor levels in the lungs. Our results suggest that VC not only prevents smoke-induced emphysema in SMP30-KO mice but also restores emphysematous lungs. Therefore, VC may provide a new therapeutic strategy for treating chronic obstructive pulmonary disease in humans.Keywords
This publication has 47 references indexed in Scilit:
- Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cellsCell Research, 2011
- Is a regenerative approach viable for the treatment of COPD?British Journal of Pharmacology, 2011
- Lysyl Oxidase, A Critical Intra- and Extra-Cellular Target in the Lung for Cigarette Smoke PathogenesisInternational Journal of Environmental Research and Public Health, 2011
- Vitamin C Enhances the Generation of Mouse and Human Induced Pluripotent Stem CellsCell Stem Cell, 2010
- Pulmonary Epithelial Neuropilin-1 Deletion Enhances Development of Cigarette Smoke–induced EmphysemaAmerican Journal of Respiratory and Critical Care Medicine, 2009
- Erasing the methyl mark: histone demethylases at the center of cellular differentiation and diseaseGenes & Development, 2008
- Molecular pathogenesis of emphysemaJCI Insight, 2008
- Senescence marker protein 30 functions as gluconolactonase in l -ascorbic acid biosynthesis, and its knockout mice are prone to scurvyProceedings of the National Academy of Sciences of the United States of America, 2006
- Collagen synthesis is required for ascorbic acid-enhanced differentiation of mouse embryonic stem cells into cardiomyocytesBiochemical and Biophysical Research Communications, 2006
- Topically Applied Vitamin C Enhances the mRNA Level of Collagens I and III, Their Processing Enzymes and Tissue Inhibitor of Matrix Metalloproteinase 1 in the Human Dermis11Part of this work was presented in poster form at the American Academy of Dermatology, San Francisco, CA, March 10–15, 2000.Journal of Investigative Dermatology, 2001